Sitemap - 2021 - Geneva Health Files
Reflections on self-publishing [2021]: Year Two, Geneva Health Files
Political Dialogue Lifts TRIPS Waiver Talks, Geneva Trade Bureaucracy Undermines It
ACT-A 2022: WHO's "greater role"to deliver on the last mile for equity
Member states could consider paying more to support WHO, some remain unwilling
The race to reach missed deadlines: COVID-19 vaccination targets & the TRIPS Waiver
TRIPS Waiver fights to stay front and center at WTO; What lies ahead for countries post-WHASS
Podcast: The Story Of The TRIPS Waiver
Is the 'Walker Process' at the WTO undermining the TRIPS Waiver?
The many shades of international cooperation in global health
The Emerging Path to the TRIPS Waiver
WHO's Commercial Determinants of Health and a nod to "transformative partnerships"
Round One to the EU & Friends: "Treaty" Option Gains Support
MSD's Pandemic Drug: The Big Moment for Voluntary Licensing; A Note on Editorial Positions
Pathogen-Sharing and the Access to Benefits: Theory And Practice
Global Health Governance Post-Pandemic: Forces of Fragmentation Meet Multilateralism
"Equity" Expands in Pandemic Treaty Discussions at WHO
The Looming "Treatment-Inequity" in COVID-19
Examining the “subtle shift” in the TRIPS Waiver talks
The ACT Accelerator Independent Review: A Missed Opportunity?
A Replenishment Model for WHO; The Questions Guiding the Pandemic Treaty Talks
France's WHO Academy; The Slippery Slope of Global Health Geopolitics
A Meeting Among the Friends of the Pandemic Treaty; Gavi wants Countries to Resell Doses to COVAX
'Lift export bans' says Africa; 100 million doses set to expire: Airfinity
TRIPS Waiver opponents ring-fenced by growing support for proposal
Of Elections and Booster Campaigns
Introducing the Geneva Health Files Podcast
The politics of surplus production & vaccine scarcity
"The idea of pathogen sharing is based on power dynamics": Q&A with Senjuti Saha
Threats of sanctions from Berlin ahead of talks in Geneva might alter support for pandemic treaty
"Health is a strategic frontline target": Guest Essay by Mukesh Kapila on the Tigray Crisis
The U.S. hopes to reshape post-pandemic governance with a "Global Health Threats Fund"
COVID-19 & The Political Imperative for Health Security
Guest Essay: "Do We Really Need a Pandemic Treaty?"
Will the SARS-CoV-2 origins debate fuel pandemic treaty talks?
Understanding Germany’s Trenchant Opposition To the TRIPS Waiver
WHO raises pitch against booster doses and vaccine prices
Where does India truly stand on the TRIPS Waiver: Q&A with Murali Neelakantan
The many promises of the mRNA tech transfer hub in Africa
The Writing on the Wall? The EU Seeks to Steer Talks Away from the TRIPS Waiver Proposal
The Mechanics of the Tech Transfer Narrative during COVID-19
COVID-19 Lessons from UNICEF: Q&A with Gian Gandhi; CEPI's COVAX Marketplace
Exclusive: Confidential Communication on the TRIPS Waiver Shows the EU's Unwillingness to Negotiate
Vaccines falling through the cracks in the regulatory mosaic
The clock is ticking on securing WHO's finances; TRIPS Waiver update
TRIPS Talks: Interview with João Aguiar Machado, EU Ambassador to the WTO
A Moment of Reckoning for the COVAX Facility; EU's Tweaks to Compulsory Licensing at the WTO
South Africa bags first mRNA tech transfer hub; The EU's push for a declaration at the WTO
The importance of the scope of the TRIPS Waiver. Talks off to a tough start at WTO
Essay: The Economics of Health For All; Announcing the Geneva Health Files Summer Fellows
Stage set for TRIPS Talks: An intense summer of negotiations for Geneva
The demand for vaccine indemnity from countries & the terms of COVAX
#WHA74 WRAP: Pandemic Treaty Talks Eclipse Prevailing Vaccine Inequities
The dash for the pandemic treaty; Understanding the Oxygen crisis: Q&A: Robert Matiru, Unitaid
The WTO Becomes the Nerve Center for Pandemic Response
Variants of Concern & Variants of Interest: SARS-CoV-2
Countries divided on ways to reform WHO emergency preparedness
COVAX counts on dose-sharing to counter vaccine crunch, vaccine diplomacy makes it worse
"A hole in the firewall": The WHO Foundation & WHO; "Green shoots" for TRIPS Waiver Talks?
WHO & WTO converge on bilateral tech transfer for vaccines. What this means for the TRIPS Waiver
Make way for the COVAX Manufacturing Taskforce
WHO’s "Bretton Woods Moment" Dimmed by Member States’ Reluctance To Pay Up More
The cautionary tale of the COVAX Facility
Pathogens-Sharing & The Pandemic Treaty: The Commercial Link
Examining the motivations for a pandemic treaty
Rich countries' stance on local production of vaccines: Smoke and mirrors
WHO donors seek a new tech transfer hub under ACT-A, C-TAP sidelined
AstraZeneca vaccine: a regulatory test; The new ACT-A strategy
Could Vaccine Nationalism Spur Disputes At The WTO; TRIPS Waiver Talks Update
The concerted push to address vaccine production shortages
The COVAX Allocation Algorithm for Vaccine Distribution
Vaccine Passports; Geneva Health Files goes paid!
"The Third Way": A key to unlock TRIPS Waiver negotiations?
Making Investigative Global Health Journalism Possible
Limits to vaccine diplomacy; TRIPS Waiver discussions deadlocked
Constraints facing the COVID-19 Technology Access Pool (C-TAP)
Geneva's trailblazing week: Ngozi Okonjo-Iweala "fresh eyes" at WTO
The ACT-A Agenda: The financialization of a pandemic?
The race against virus variants
Reading the COVAX forecast; Cracks in the opposition to the TRIPS Waiver?
COVAX & the question of liability: COVID-19 vaccines
Q&A: Germany's Björn Kümmel on WHO financing
A pandemic treaty: reforming global health security; TRIPS Waiver update at WTO
Vaccines & Virus Concerns at WHO Board; TRIPS Waiver talks at WTO
The Politics of Pathogens-Sharing
W.H.O. Executive Board Meeting: Curtain Raiser